Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vector-Borne Transmission of Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04650815
What this trial is testing

Malaria Transmission in Humans and Mosquitoes at the Area of Sabou, Burkina Faso

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 608
Not applicableStudy completedNCT03177993
What this trial is testing

Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji

Who this might be right for
Lymphatic FilariasesScabiesImpetigo+1 more
Washington University School of Medicine 4,773
Early research (Phase 1)Study completedNCT02013687
What this trial is testing

Safety and Immunogenicity of Plant-Derived Pfs25 VLP-FhCMB Malaria Transmission Blocking Vaccine in Healthy Adults

Who this might be right for
Malaria
Fraunhofer, Center for Molecular Biotechnology 44
Not applicableStudy completedNCT00440752
What this trial is testing

The Impact of Artemether-Lumefantrine on Genes Associated With Antimalarial Resistance

Who this might be right for
Falciparum MalariaAntimalarials
Tropical Medicine Research Institute 100
Large-scale testing (Phase 3)Study completedNCT01426243
What this trial is testing

The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.

Who this might be right for
HIV InfectionYellow Fever
French National Agency for Research on AIDS and Viral Hepatitis 71
Post-approval studies (Phase 4)Study completedNCT02784743
What this trial is testing

Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali

Who this might be right for
Lymphatic Filariasis
Centre d'Appui à la lutte contre la Maladie 1,139
Early research (Phase 1)Study completedNCT04238689
What this trial is testing

Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of TB31F

Who this might be right for
Malaria,Falciparum
Radboud University Medical Center 25
Early research (Phase 1)WithdrawnNCT00977899
What this trial is testing

Phase 1 Study of the Safety and Immunogenicity of a Malaria Transmission-blocking Pfs25-Pfs25 Conjugate Vaccine

Who this might be right for
MalariaMalaria VaccinesPlasmodium Falciparum Malaria
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Large-scale testing (Phase 3)Study completedNCT00561899
What this trial is testing

Comparison of Three Drug Combinations for Intermittent Treatment of Malaria in Children

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 1,295
Large-scale testing (Phase 3)Study completedNCT00000432
What this trial is testing

Lyme Disease Prevention Program

Who this might be right for
Lyme DiseaseTick-Borne Diseases
Brigham and Women's Hospital 20,000
Early research (Phase 1)Study completedNCT00384787
What this trial is testing

Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Early research (Phase 1)Study completedNCT06412926
What this trial is testing

Learn About How Much Emodepside Gets Absorbed in the Blood and How Food Affects Its Absorption When Given as a New Type of Tablet to Healthy Participants

Who this might be right for
Soil-transmitted Helminth InfectionOnchocerciasis (River Blindness)
Bayer 14
Not applicableStudy completedNCT06268691
What this trial is testing

Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating

Who this might be right for
DengueVector Borne DiseasesArbovirus Infections+2 more
Rocio Cardenas Sanchez 35,000
Large-scale testing (Phase 3)Study completedNCT04049916
What this trial is testing

Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum Transmission

Who this might be right for
Malaria,Falciparum
London School of Hygiene and Tropical Medicine 100
Large-scale testing (Phase 3)Study completedNCT00646126
What this trial is testing

Antimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria Transmission

Who this might be right for
Plasmodium FalciparumAsymptomatic ParataemiaSub Patent Parasitaemia
Tropical Medicine Research Institute
Not applicableStudy completedNCT03172221
What this trial is testing

Clinical Performance of the HRP2 HS-RDT for Malaria Diagnosis in Pregnant Women

Who this might be right for
Plasmodium FalciparumPregnancy MalariaDiagnoses Disease
Foundation for Innovative New Diagnostics, Switzerland 880
Large-scale testing (Phase 3)Study completedNCT00970879
What this trial is testing

Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus Mefloquine

Who this might be right for
Malaria in PregnancyHIV Infections
Institut de Recherche pour le Developpement 430
Testing effectiveness (Phase 2)Study completedNCT02315703
What this trial is testing

Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 393
Not applicableStudy completedNCT01062386
What this trial is testing

Malaria Survey in Mbarara District, Uganda 2010

Who this might be right for
Malaria
Epicentre 2,320
Testing effectiveness (Phase 2)Study completedNCT00123968
What this trial is testing

Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 326
Next Page